GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Sabra Health Care REIT Inc (NAS:SBRA) » Definitions » ROE %

Sabra Health Care REIT (Sabra Health Care REIT) ROE % : 2.42% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Sabra Health Care REIT ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Sabra Health Care REIT's annualized net income for the quarter that ended in Dec. 2023 was $68.6 Mil. Sabra Health Care REIT's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $2,835.7 Mil. Therefore, Sabra Health Care REIT's annualized ROE % for the quarter that ended in Dec. 2023 was 2.42%.

The historical rank and industry rank for Sabra Health Care REIT's ROE % or its related term are showing as below:

SBRA' s ROE % Range Over the Past 10 Years
Min: -3.34   Med: 5.36   Max: 8.35
Current: 0.47

During the past 13 years, Sabra Health Care REIT's highest ROE % was 8.35%. The lowest was -3.34%. And the median was 5.36%.

SBRA's ROE % is ranked worse than
68.88% of 800 companies
in the REITs industry
Industry Median: 4.21 vs SBRA: 0.47

Sabra Health Care REIT ROE % Historical Data

The historical data trend for Sabra Health Care REIT's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sabra Health Care REIT ROE % Chart

Sabra Health Care REIT Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.05 4.01 -3.34 -2.41 0.47

Sabra Health Care REIT Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.85 -1.26 2.86 -2.08 2.42

Competitive Comparison of Sabra Health Care REIT's ROE %

For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sabra Health Care REIT's ROE % Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Sabra Health Care REIT's ROE % distribution charts can be found below:

* The bar in red indicates where Sabra Health Care REIT's ROE % falls into.



Sabra Health Care REIT ROE % Calculation

Sabra Health Care REIT's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=13.756/( (3056.395+2802.534)/ 2 )
=13.756/2929.4645
=0.47 %

Sabra Health Care REIT's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=68.624/( (2868.853+2802.534)/ 2 )
=68.624/2835.6935
=2.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Sabra Health Care REIT  (NAS:SBRA) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=68.624/2835.6935
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(68.624 / 653.588)*(653.588 / 5383.356)*(5383.356 / 2835.6935)
=Net Margin %*Asset Turnover*Equity Multiplier
=10.5 %*0.1214*1.8984
=ROA %*Equity Multiplier
=1.27 %*1.8984
=2.42 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=68.624/2835.6935
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (68.624 / 70.596) * (70.596 / 217.288) * (217.288 / 653.588) * (653.588 / 5383.356) * (5383.356 / 2835.6935)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9721 * 0.3249 * 33.25 % * 0.1214 * 1.8984
=2.42 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Sabra Health Care REIT ROE % Related Terms

Thank you for viewing the detailed overview of Sabra Health Care REIT's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sabra Health Care REIT (Sabra Health Care REIT) Business Description

Traded in Other Exchanges
Address
18500 Von Karman Avenue, Suite 550, Irvine, CA, USA, 92612
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities. The company considers merger and acquisition investment as a component of its operational growth strategy. Sabra works with existing operators to identify strategic development opportunities.
Executives
Michael Lourenco Costa officer: Executive VP & CAO 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Catherine Cusack director 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Andrews Harold W. Jr. officer: Executive VP, CFO & Secretary C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612
Michael J Foster director 36 GROVE STREET, NEW CANAAN CT 06840
Ann Kono director 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Porter Clifton J Ii director 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Robert A. Ettl director C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612
Richard K Matros director, officer: CEO and President
Raymond J Lewis director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Lynne S Katzmann director 18500 VON KARMAN AVENUE,SUITE 550, IRVINE CA 92612
Milton J Walters director C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN AVENUE, SUITE 550, IRVINE CA 92612
Ronald G Geary director 10140 LINN STATION RD, LOUISVILLE KY 40223-3813
Jeffrey A. Malehorn director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Talya Nevo-hacohen officer: Executive VP, CIO & Treasurer C/O SABRA HEALTH CARE REIT, INC., 18500 VON KARMAN, SUITE 550, IRVINE CA 92612
Craig A. Barbarosh director 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305